Urbanization elicits a more atherogenic lipoprotein profile in carriers of the apolipoprotein A-IV-2 allele than in A-IV-1 homozygotes

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 6, 1997, Pages 1074-1081

  Campos, Hannia ^b   López Miranda, José ^a   Rodríguez, Carmen ^a   Albajar, Marta ^a   Schaefer, Ernst J ^a   Ordovás, José M ^a  

^a TUFTS UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cholesterol; Dietary intake; Gene polymorphism; LDL particle size; Smoking

Indexed keywords

APOLIPOPROTEIN A4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CIGARETTE SMOKING; CORONARY RISK; DISEASE PREDISPOSITION; FAT INTAKE; FEMALE; GENETIC POLYMORPHISM; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PRIORITY JOURNAL; RISK ASSESSMENT; RURAL POPULATION; URBAN POPULATION;

EID: 0030987448     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.6.1074     Document Type: Article

References (37)

1. Evans JR, Hall KL, Warford J. Health care in the developing world: problems of scarcity and choice. N Engl J Med. 1981:305:1117-1127. Shattuck lecture.
2. Campos H, Mala L, Sues X, Vives M, Ordovas JM, Schaefer EJ. Prevalence of cardiovascular risk factors in rural and urban Puriscal, Costa Rica. Circulation. 1992;85:648-658.
3. . World Health Organization. World Health Statistics Annual. Geneva, Switzerland: World Health Organization; 1992.
4. Campos H, Willett WC. Peterson RM, Sues X, Bailey SM, Wilson PWF, Posner BM, Ordovas JM, Schaefer EJ. Nutrient intake comparisons between Framingham and rural and urban Puriscal, Costa Rica: associations with lipids, lipoproteins, apolipoproteins, and LDL particle size. Arterioscler Thromb. 1991;11:1089-1099.
5. Campos H, Genest J, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PWF, Schaefer EJ. Low-density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992; 12:187-195.
6. Krauss RM. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol. 1994;5:339-349.
7. Dreon DM, Krauss RM. Gene-diet interactions in lipoprotein metabolism. In: Lusis AJ, Rotter JL, Sparkes RS, eds. Molecular Genetics of Coronary Artery Disease: Candidate Genes and Processes in Atherosclerosis. Basel, Switzerland: Karger; 1992:325-348. No. 14 of Monographs in Human Genetics.
8. Mahley RW, Innerarity TL, Rail SC Jr, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984;25:1277-1294.
9. Green PHR, Glickman RM, Riley JW, Quinet E. Human apolipoprotein A-IV: intestinal origin and distribution in plasma. J Clin Invest. 1980;65:911-919.
10. Goldberg IJ, Scheraldi CA, Yacoub IK, Saxena U, Bisgaier CL. Lipoprotein apoC-II activation of lipoprotein lipase. modulation by apolipoprotein A-lV.J Biol Chem. 1990;265:4266-4272.
11. Weinberg RB, Jordan MK, Steinmetz A. Distinctive structure and function of human apolipoprotein variant apoA-lV-2. J Biol Chem. 1990;265:18372-18378.
12. Tenkanen H, Lukka M, Jauhiainen M, Metso J, Baumann M, Peltonen L, Ehnholm C. The mutation causing the common apolipoprotein A-IV polymorphism is a glutamine to histidine substitution of amino acid 360. Arterioscler Thromb. 1991;11:851-856.
13. Applebaum-Bowden D. Lipases and lecithin:cholesterol acyltransferase in the control of lipoprotein metabolism. Curr Opin Lipidol. 1995;6:130-135.
14. Asakawa J, Takahashi N, Rosenblum BB, Neel JV. Two dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese. Hum Genet. 1985:70:222-230.
15. Kamboh MI, Ferrell RE. Genetic studies of human apolipoproteins, I: polymorphism of apolipoprotein A-IV. Am J Hum Genet. 1987;41: 119-127.
16. Sepehrnia B, Kamboh MI, Adams-Campbell LL, Nwankwo M, Ferrell RE. Genetic studies of human apolipoproteins, VII: population distribution of polymorphisms of apolipoproteins A-I, A-II, A-IV, C-II, E, and H in Nigeria. Am J Hum Genet. 1988;43:847-853.
17. Menzel HJ, Boerwinkle E, Schrangl-Will S, Utermann G. Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet. 1988:79:368-378.
18. Menzel HJ, Sigurdsson G, Boerwinkle E, Schrangl-Will S, Dieplinger H, Utermann G. Frequency and effect of apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet. 1990:84:344-346.
19. Hanis CL, Douglas TC, Hewett-Emmett D. Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Hum Genet. 1991;86:323-325.
20. Ehnholm C, Tenkanen H, de Knijff P, Havekes L, Rosseneu M, Menzel HJ, Tiret L. Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe: Relations to plasma lipoproteins and to history of myocardial infarction: the EARS study: European Atherosclerosis Research Study. Atherosclerosis. 1994;107:229-238.
21. Lohse P, Kindt MR, Rader DJ, Brewer HB Jr. Genetic polymorphism of human plasma A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene. J Biol Chem. 1990:265:10061-10064.
22. McCombs RJ, Marcadis DE, Ellis J, Weinberg RB. Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Engl J Med. 1994:331:706-710.
23. Mata P, Ordovás JM, López-Miranda J, Lichtenstein AH, Clevidence B, Judd JT, Schaefer EJ. ApoA-IV phenotype affects diet-induced plasma LDL cholesterol lowering. Arterioscler Thromb. 1994;14: 884-891.
24. Rewers M, Kamboh MI, Hoag S, Shetterly SM, Ferrell RE, Hamman RF. ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. Diabetes. 1994;43:1485-1489.
25. Hall C. Costa Rica. A Geographical Interpretation in Historical Perspective. Boulder, Colo: Westview Press, Ine; 1985. Dellplain Latin American Studies, No. 17.
26. Campos H, Bailey SM, Gussak LS, Siles X, Ordovas JM, Schaefer EJ. Relationships of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. Arterioscler Thromb. 1991;11:1077-1088.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
28. Willett WC, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124:17-27.
29. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: results of the Framingham Offspring Study. Arteriosclerosis. 1987;7:483-490.
30. McCall MR, van den Berg JJ, Kuypers FA, Tribble DL, Krauss RM, Knoff LJ, Forte TM. Modification of LCAT activity and HDL structure: new links between cigarette smoke and coronary heart disease risk. Aneriosder Thromb. 1994;14:248-253.
31. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Aneriosder Thromb. 1992;12:911-919.
32. Rotter JI, Bu X, Cantor RM, Warden CH, Brown J, Gray RJ, Blanche PJ, Krauss RM, Lusis AJ. Multiple genes determine LDL particle ize phenotype in coronary artery disease families. Circulation. 1994;90(suppl I):I-509. Abstract.
33. Campos H, Dreon DM, Krauss RM. Associations of hepatic lipase and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. J Lipid Res. 1995;36:462-472.
34. Campos H, Blijlevens E, McNamara JR, Ordovas JM, Posner BM, Wilson PWF, Castelli WP, Schaefer EJ. Low density lipoprotein particle size distribution: results from the Framingham Offspring Study. Arterioscler Thromb. 1992;12:1410-1419.
35. Duverger N, Ghalim N, Theret N, Fruchart JC, Castro G, Brewer HBJ. Lipoproteins containing apoA-IV: composition and relation to cholesterol esterification. Biochim Biophys Acta. 1994;1211:23-28.
36. Anantharamaiah GM, Venkatachalapathi YV, Brouillette CG, Segrest JP. Use of synthetic peptide analogues to localize lecithin: cholesterol acyltransferase activating domain in apolipoprotein A-I. Arteriosclerosis. 1990;10:95-105.
37. Bèrard A, Brousseau M, Hoeg JM, Vaisman B, Sakai N, Wood D, Hoyt R, Marcovina S, Brewer HBJ, Santamaría-Fojo S. LCAT modulates dietary lipid response in hLCAT transgenic rabbits. Circulation. 1995;92(suppl I):I-351. Abstract.